Ceva launches new Vectormune ® website >
Website provides educational resources for poultry professionals, as well as comprehensive information about their vector vaccines range.
Ceva souligne la nécessité d’une plus grande INNOVATION dans le couvoir pour répondre à la demande mondiale croissante pour la viande de volaille >
La société lance Cevac IBird ® un vaccin vivant atténué contre le virus IB, qui vient s’ajouter à son portefeuille de 16 vaccins élaborés grâce aux nouvelles technologies
Ceva stresses the need for more INNOVATION in the hatchery to drive growing global demand for poultry meat >
Company launches Cevac IBird ® a live, attenuated IB vaccine, to add to its portfolio of 16 new technology vaccines
Ceva will be at the 18th World’s Poultry Congress >
Congress Center, Nantes Events Center «La Cité»
Ceva’s growth continues despite difficult market conditions >
Libourne, France, 22 July, 2013: Consolidated sales of the Ceva Group reached €310m in the first 6 months of 2013, up by 2%, 4.2% on the previous year at a constant perimeter and exchange rates. Ceva recorded solid growth of 9% on a constant basis (constant perimeter and exchange rates), if one excludes 2 factors: Vectra® sales in the United States, which were less than anticipated, due to a...
Ceva signs a Joint-venture agreement in China to help control zoonoses >
Joint-venture with Jinyu Baoling will produce brucellosis vaccines in Inner Mongolia
Signature of a scientific collaboration protocol about avian influenza with South China Agricultural University >
Paris, May 29th 2013 1- Ceva, a socially responsible company committed to the well-being of the planet Ceva Santé Animale is a multi-national French based animal health company that counts over 3000 employees, 800 of whom are based in France, with a turnover which exceeds 600 M€. The company was formed in 1999, when Sanofi sold its veterinary business. Since then, Ceva has seen constant and spectacular...
2013 reprodAction Scientific Meeting - April 16-17th >
“Management and reproduction of dairy heifers”
Ceva uses creative thinking in new approach to innovation in Industrial equity >
Libourne, France 2nd May 2013: Most of the time innovation in the bio-pharmaceutical field is associated with the scientific R&D teams. But having the latest technology vaccines is of little value if you cannot produce them efficiently, on time and to the highest quality standards. As a result, Ceva recently organized its first industrial innovation day – entitled Together, Creative Innovation,...
Ceva creates 60 strong teams to support innovative vaccination services on farm and in the hatchery >
Recent research showed Ceva that their customers want more than just good vaccines; they want 100% of their birds correctly vaccinated.